Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Broadfin Capital’

Broadfin Kevin Kotler

Kevin Kotler, Broadfin Capital Increase Holding Of Progenics Pharmaceuticals, Inc. (PGNX)

Kevin Kotler is bullish on Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and has decided to boost his fund’s investment in the stock. Kotler’......(read more)
Izzy Englander of MILLENNIUM MANAGEMENT

Israel Englander and Millennium Management Further Decrease Exposure To Liberator Medical Holdings Inc (LBMH)

Israel Englander and Millennium Management have further decreased their stake in Liberator Medical Holdings Inc (NYSEMKT:LBMH) and have sold 175,000......(read more)

RA Capital Management Sells 800,000 Shares of Achillion Pharmaceuticals Inc. (ACHN)

RA Capital Management, managed by Peter Kolchinsky, has sold 800,000 shares of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) in two transactions for about......(read more)

Camber Capital Management Reveals New Position in Cardica, Inc. (CRDC)

Stephen Dubois‘ Camber Capital Management revealed a new stake in Cardica, Inc. (NASDAQ:CRDC). According to a recent 13G filing, the fund now......(read more)
Broadfin Kevin Kotler

Broadfin Capital Initiates New Positions In Corium International Inc (CORI), AMAG Pharmaceuticals Inc. (AMAG) and La Jolla Pharmaceutical Company (LJPC)

In three recent filings,  Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Broadfin Capital Reveals New Stake in Dipexium Pharmaceuticals (DPRX)

A new filing with the SEC, Kevin Kotler and his hedge fund Broadfin Capital revealed new stake in Dipexium Pharmaceuticals, Inc (NASDAQ:DPRX). In......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Broadfin Capital’s and MELA Sciences (MELA)

A new filing with the SEC revealed, Kevin Kotler and his hedge fund Broadfin Capital revealed a trimmed stake in MELA Sciences, Inc (NASDAQ:MELA).......(read more)

Sabby Management Adds Bioline RX Ltd (BLRX) & Recro Pharma Inc (REPH) to Its Equity Portfolio

In a couple of new filings with the SEC, Hal Mintz‘s Sabby Management disclosed adding two companies to its equity portfolio: Bioline RX Ltd (NASDAQ......(read more)
Broadfin Kevin Kotler

Broadfin Capital Initiates Stake in Newly Public Recro Pharma Inc (REPH)

Broadfin Capital, managed by Kevin Kotler, has disclosed in a new filing with the U.S. Securities and Exchange Commission holding shares of Recro Pharma......(read more)
Broadfin Kevin Kotler

Broadfin Capital Initiates Stake in Pernix Therapeutics (PTX)

Last night, Broadfin Capital, a healthcare focused hedge fund managed by Kevin Kotler, disclosed in a Securities and Exchange Commission filing that it......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Broadfin Capital Reports New Stake In MELA Sciences Inc (MELA)

Kevin Kotler’s Broadfin Capital, in its latest filing with the Securities and Exchange Commission, has reported ownership of 9.09 million shares of......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Broadfin Capital Initiates Stake in Eleven Biotherapeutics (EBIO) Following Its IPO

Broadfin Capital, led by Kevin Kotler, in a filing with the Securities and Exchange Commission, reported initiating a position in Eleven Biotherapeutics......(read more)

Steven Cohen Also Initiates Stake in Retrophin Inc (RTRX)

Steven Cohen, in a new filing with the SEC disclosed initiating a stake in Retrophin Inc (NASDAQ:RTRX). According to the filing, Mr. Cohen holds a total......(read more)
Broadfin Kevin Kotler

Broadfin Capital Initiates a Stake in Retrophin Inc (RTRX) Following Its Listing on NASDAQ

Kevin Kotler’s Broadfin Capital has revealed a new stake in Retrophin Inc (NASDAQ:RTRX), which amasses 6.93% of the company’s common stock, it contains......(read more)
Broadfin Kevin Kotler

Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)

Kevin Kotler‘s Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed. Broadfin reported......(read more)

Deerfield Management Initiates Passive Stake in Horizon Pharma Inc (HZNP)

James E. Flynn‘s healthcare-focused Deerfield Management has revealed, in a new filing with the SEC, initiating a passive stake in Horizon Pharma......(read more)
Broadfin Kevin Kotler

Kevin Kotler, Broadfin Capital Raise Holding in Derma Sciences Inc (DSCI)

Kevin Kotler‘s Broadfin Capital has increased its position in Derma Sciences Inc (NASDAQ:DSCI). According to a new filing with the SEC, Broadfin......(read more)
Broadfin Kevin Kotler

Broadfin Capital Boosts Stake in Horizon Pharma, Adds Alliqua to Its Equity Portfolio

In two newly amended filings with the SEC, Kevin Kotler‘s Broadfin Capital disclosed moves into Horizon Pharma Inc (NASDAQ:HZNP), and Alliqua......(read more)
Broadfin Kevin Kotler

Broadfin Capital, Kevin Kotler Disclose a 5.7% Stake in Discovery Laboratories

Broadfin Capital, Discovery Laboratories: In a new 13G filing just reported to the SEC, Broadfin Capital, managed by Kevin Kotler, disclosed a 5.77%......(read more)
Broadfin Kevin Kotler

Kevin Kotler & Broadfin Capital Take a 5.2% Stake in Biodel

Biodel, Broadfin Capital: In a 13G filing reported a few minutes ago, Kevin Kotler‘s Broadfin Capital disclosed ownership of a 5.2% stake in Biodel......(read more)

How One Anacor Pharmaceuticals Insider is Making Bank

Anacor Pharmaceuticals, Geoffrey Parker: In a recent Form 4 filing with the SEC, M. Geoffrey Parker, Senior Vice President and CFO at Anacor Pharmaceuticals......(read more)

Broadfin Capital Opens a Stake in Celsus, Another Biotech Company Today

Broadfin Capital, Celsus: Broadfin Capital, managed by Kevin Kotler, just disclosed a position in Celsus Therapeutics (OTCQB: CLSXY). According to......(read more)
Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Kevin Kotler’s Broadfin Capital Joins HealthCor in Idera

Broadfin Capital, Idera Pharmaceuticals: Just now, Kevin Kotler’s Broadfin Capital disclosed adding Idera Pharmaceuticals Inc (NASDAQ:IDRA) to......(read more)
CAS Medical Systems Inc (NASDAQ:CASM)

Broadfin Capital Thinks CAS Medical Systems Inc (CASM) Is Worth Some Cash

Even though passive “hedgies” do not benefit from the same amount of coverage as their activist peers, their moves should also be watched......(read more)
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It

Is Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) a good investment? To the average investor, there are tons of indicators shareholders can use to watch......(read more)
BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)

Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) a good investment? At the moment, there are many indicators market participants can use to......(read more)
Insulet Corporation (NASDAQ:PODD)

Should You Avoid Insulet Corporation (PODD)?

To many of your peers, hedge funds are assumed to be delayed, outdated financial tools of a period lost to current times. Although there are more than......(read more)

Do Hedge Funds and Insiders Love Integra Lifesciences Holdings Corp (IART)?

If you were to ask many market players, hedge funds are viewed as useless, old investment vehicles of an era lost to time. Although there are over 8,000......(read more)
Masimo Corporation (NASDAQ:MASI)

Masimo Corporation (MASI): Are Hedge Funds Right About This Stock?

At the moment, there are plenty of gauges market participants can use to monitor publicly traded companies. Some of the most under-the-radar are hedge......(read more)
Cutera, Inc. (NASDAQ:CUTR)

Hedge Funds Aren’t Crazy About Cutera, Inc. (CUTR) Anymore

Now, according to many traders, hedge funds are perceived as useless, old investment vehicles of a period lost to current times. Although there are In......(read more)
Pain Therapeutics, Inc. (NASDAQ:PTIE)

Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?

Should Pain Therapeutics, Inc. (NASDAQ:PTIE) investors track the following data? In the eyes of many investors, hedge funds are viewed as overrated,......(read more)
MAKO Surgical Corp. (NASDAQ:MAKO)

Robotic Surgery News: Intuitive Surgical, Inc. (ISRG)’s Market Saturation, MAKO Surgical Corp. (MAKO)’s Traders

Editor’s Note: Intuitive Surgical, Inc. (NASDAQ:ISRG), MAKO Surgical Corp. (NASDAQ:MAKO) Intuitive Surgical Market Saturation Could Be Brief (......(read more)
Alkermes Plc (NASDAQ:ALKS)

Hedge Funds Are Crazy About Alkermes Plc (ALKS)

What’s a smart Alkermes Plc (NASDAQ:ALKS) investor to do? In the financial world, there are plenty of indicators shareholders can use to watch......(read more)
Impax Laboratories Inc (NASDAQ:IPXL)

Hedge Funds Are Buying Impax Laboratories Inc (IPXL)

Is Impax Laboratories Inc (NASDAQ:IPXL) a good investment? At the moment, there are tons of indicators shareholders can use to analyze publicly traded......(read more)
Depomed Inc (NASDAQ:DEPO)

Depomed Inc (DEPO): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?

Should Depomed Inc (NASDAQ:DEPO) investors track the following data? In the eyes of many market players, hedge funds are viewed as delayed, outdated......(read more)
Hi-Tech Pharmacal Co. (NASDAQ:HITK)

Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged

Should Hi-Tech Pharmacal Co. (NASDAQ:HITK) investors track the following data? To the average investor, there are tons of gauges investors can use to......(read more)
Merit Medical Systems, Inc. (NASDAQ:MMSI)

Merit Medical Systems, Inc. (MMSI): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?

In the 21st century investor’s toolkit, there are a multitude of methods shareholders can use to track Mr. Market. Some of the most underrated are hedge......(read more)
MAKO Surgical Corp. (NASDAQ:MAKO)

Hedge Funds Are Selling MAKO Surgical Corp. (MAKO)

In today’s marketplace, there are many gauges market participants can use to track publicly traded companies. A duo of the most under-the-radar are......(read more)

Natus Medical Inc (BABY): Are Hedge Funds Right About This Stock?

Should a Natus Medical Inc (NASDAQ:BABY) track the following data? If you were to ask many of your fellow readers, hedge funds are seen as useless, outdated......(read more)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a good investment? In the eyes of many investors, hedge funds are seen as useless, outdated investment tools......(read more)
Emergent Biosolutions Inc (NYSE:EBS)

Hedge Funds Are Selling Emergent Biosolutions Inc (EBS)

To many investors, hedge funds are viewed as delayed, outdated financial vehicles of a forgotten age. Although there are more than 8,000 hedge funds with......(read more)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and......(read more)
Alere Inc

Do Hedge Funds and Insiders Love Alere Inc (ALR)?

Now, according to many market players, hedge funds are assumed to be bloated, old investment tools of a period lost to current times. Although there are......(read more)

This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)

Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds’ portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm......(read more)
Broadfin Kevin Kotler

Hedge Funds Are Buying Solta Medical Inc (SLTM)

Is Solta Medical Inc (NASDAQ:SLTM) worth your attention right now? Investors who are in the know are getting more bullish. The number of bullish hedge......(read more)
Broadfin Kevin Kotler

DURECT Corporation (DRRX): Hedge Funds and Insiders Are Bullish, What Should You Do?

DURECT Corporation (NASDAQ:DRRX) has experienced an increase in hedge fund interest recently. To most stock holders, hedge funds are assumed to be underperforming......(read more)

AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?

AtriCure Inc. (NASDAQ:ATRC) has experienced an increase in enthusiasm from smart money of late. In today’s marketplace, there are tons of indicators......(read more)
Chuck Royce

Hedge Funds Are Betting On Globus Medical Inc (GMED)

Globus Medical Inc (NYSE:GMED) has experienced an increase in hedge fund interest of late. In the eyes of most traders, hedge funds are seen as slow,......(read more)

Is Novadaq Technologies Inc. (NVDQ) Going to Burn These Hedge Funds?

Novadaq Technologies Inc. (NASDAQ:NVDQ) has seen an increase in hedge fund interest lately. In the financial world, there are a multitude of gauges market......(read more)
Insulet Corporation (NASDAQ:PODD)

Should You Buy Insulet Corporation (PODD)?

Insulet Corporation (NASDAQ:PODD) was in 14 hedge funds’ portfolio at the end of the first quarter of 2013. PODD has experienced an increase in......(read more)